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Abstract 
Objectives: Performance-based outcome measures (PBOM) are suggested to evaluate 
change in function during rehabilitation after total knee arthroplasty (TKA). The purpose 
of this study was to evaluate the measurement properties of the 30-Second Chair Stand 
Test (30CST) and 10-Metre Walk Test (10MWT) in patients following TKA. 
Methods: Eighty-three patients completed two PBOM on three occasions following 
surgery. Patients also completed the Western Ontario and McMaster Universities 
Osteoarthritis Index and Global Rating of Change (GRC). 
Results: Intraclass correlation coefficients ranged from 0.82 to 0.96. The standard errors 
of measurement at 6 and 12 weeks postoperative, respectively, were: 30CST ±0.67 and 
±0.79, 10MWT ±1.05 and ±0.57. Minimal detectable changes (90% confidence level) 
were: 30CST ±1.56 and ±1.84, 10MWT ±2.43 and ±1.32. Correlations between change in 
PBOM and GRC ranged from -0.16 to 0.34. 
Conclusions: These results support the reliability, validity and clinical use of the 30CST 
and 10MWT during rehabilitation following TKA. 
 
Key Words: performance-based outcome measures, rehabilitation, total knee 
arthroplasty, psychometric measurement properties 
 
 
 
 
 
 
iv 
 
Summary for Lay Audience 
 
Rehabilitation is important to achieve optimal results following total knee arthroplasty 
(TKA). The goal of rehabilitation is to maximize functional independence. One method 
to assess outcomes is to select appropriate measures that quantify improvements in 
physical function. Performance-Based Outcome Measures (PBOM) of physical function 
are more likely to exemplify a change in function than self-report measures alone. This 
thesis evaluated the measurement properties of the 30-Second Chair Stand Test (30CST) 
and 10-Metre Walk Test (10MWT) in patients following total knee arthroplasty. The 
results of the study support the reliability, validity, and clinical use of the 30CST and 
10MWT during rehabilitation following surgery.  Integrating reliable and valid PBOM 
into clinical practice is essential for patients, physiotherapists, and surgeons to measure 
change in function during rehabilitation. This protocol may ultimately assist with clinical 
decision-making and guide best practice.  
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Chapter 1 
Introduction 
According to the Canadian Institute for Health Information, more than 70,000 knee 
replacements were performed in Canada in 2017-18.  Approximately 65,000 were 
primary replacements.  These numbers have increased by 17% in the last 5 years.1 
Similar trends in annual growth in incidence of total knee arthroplasty (TKA) have been 
observed world-wide.2 In 2011, Kurtz et al observed a 27-fold range of TKA utilization 
rates between 18 different countries, including the United States, Denmark, the 
Netherlands and Australia. They estimated 1,324,000 primary and revision TKA 
procedures are completed globally each year, with this number expected to continue to 
rise.2 The 25-year survivorship for total knee arthroplasty is estimated to be 82%.3 
Despite overall favourable results many studies estimate that up to 20% of patients are 
dissatisfied following a total knee arthroplasty.  Unfulfilled expectations are strongly 
associated with poor satisfaction.4,5  
Rehabilitation is important to achieve optimal results following total knee arthroplasty.  
The goals of rehabilitation focus on maximizing functional independence and minimizing 
complications.6 Systematic reviews conclude that no one approach is superior when 
recommending duration and delivery of care.7 One method to assess outcomes is to select 
appropriate measures that quantify improvements in physical function.  Self-report 
measures are commonly used following surgery due to the ease of administration; 
however, evidence suggests that these types of measures may fail to capture important 
functional improvements following TKA.  Self-report measures provide an analysis of a 
patient’s perception of their functional abilities.  A patient’s perception of task 
importance can influence their response 8 along with difficulty separating pain from the 
ability to perform the activity.9 Because of this, performance-based outcome measures 
(PBOM) of physical function are more likely to exemplify a change in function than self-
report measures alone.9 Previous research has examined the association between self-
report and performance-based measures and found correlations ranging between 0.02 and 
0.59.10 
2 
 
Recommended performance-based measures to assess function in people with hip and 
knee osteoarthritis, those awaiting joint replacement, and following joint replacement 
have been outlined by various groups such as The Osteoarthritis Research Society 
International (OARSI), Rehabilitative Care Alliance (RCA) and various clinical 
researchers.11–13 Although the recommended measures may vary slightly from group to 
group, they often include a measure of gait speed and lower extremity functional strength 
and endurance integrated into typical activities relevant to the patient population such as 
climbing stairs, getting in and out of a chair and walking. 
OARSI’s recommended minimum set of PBOM include: the 30-second chair stand test, 
40 metre fast-paced walk test and stair climb test.12 Due to the complexity of the 40 metre 
fast-paced walk test and identified limitations, the 10 metre fast-paced walk test was 
recognized as an acceptable alternative.  These measures focus on a population diagnosed 
with osteoarthritis (OA), as well as those following joint replacement.  The psychometric 
properties of these measures have been evaluated extensively in those with knee OA who 
may be awaiting TKA, however, to our knowledge, the reliability and validity has not 
been examined in the TKA population during postoperative rehabilitation. For this study 
evaluating measurement properties and establishing point estimates at different points in 
recovery was an important part of the research design.  Change in functional status 
following TKA is variable and each patient’s trajectory is unique.  Although potential for 
recovery following TKA can occur over a 12 month period, the greatest improvement in 
physical impairments and activity limitations occurs in the first twelve weeks or three 
months.14,15 As the rate of change in function is greater in the initial stage of recovery; we 
cannot assume that the measurement properties at different time points during this phase 
are identical.  
Integrating reliable and valid PBOMs into clinical practice is essential for patients, 
physiotherapists, and surgeons to measure change in function during postoperative 
rehabilitation following TKA and may ultimately assist with clinical decision-making and 
guide best practice in rehabilitation. 
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This study will evaluate the measurement properties of the 30-Second Chair Stand Test 
(30CST) and 10-Metre Walk Test (10MWT) in patients during postoperative 
rehabilitation following TKA.   
Objectives:  
1) examine test-retest reliability of the 30CST and 10MWT. 
2) evaluate the longitudinal validity of the 30CST and 10MWT. 
3) explore the concurrent validity of the 30CST,10MWT and the Western Ontario 
and McMaster Universities Osteoarthritis Index (WOMAC) score. 
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Chapter 2 
Literature Review 
 
Osteoarthritis 
Osteoarthritis is a common degenerative joint disease.  Not only does it target the 
articular cartilage it also affects the surrounding tissue structures.  Chronic low-grade 
inflammation contributes to the initiation and progression of the disease.16,17 Knee OA is 
characterized by progressive loss and destruction of articular cartilage, thickening of 
subchondral bone, formation of osteophytes, inflammation of the synovium, degeneration 
of ligaments and menisci and hypertrophy of the joint capsule leading to loss of normal 
joint function.17,18 The result of this disease can be characterized by joint pain, swelling 
and stiffness that leads to activity limitations, participation restrictions, sleep interruption, 
fatigue, depression, anxiety, loss of independence and overall decreased quality of life.19   
OA affects over 250 million people globally or 4% of the world’s population.  
Worldwide estimates are that 9.6% of men and 18% of women over 60 years of age have 
symptomatic OA.19,20 The prevalence of OA continues to increase with age, as does the 
increase in risk factors for OA such as obesity.19,21 
The economic and health burden that OA presents is significant and continues to grow 
with the aging population and increased demands for effective interventions.  Sharif et 
al.,22 estimate that the total direct cost of OA from 2010 to 2031 in Canada will rise from 
2.9 billion to 7.6 billion.  These costs include: hospitalization, outpatient services, 
alternative care/out of pocket, drugs, rehabilitation and side effect of drugs.  The size of 
the working population with OA will also rise leading to increased productivity costs of 
work loss equaling 17.5 billion.23 
In 2016 OARSI submitted a document to the U.S Food and Drug Administration titled 
“Osteoarthritis: A Serious Disease”.19  Along with pain, loss of function and increased 
mortality OA is also associated with increased comorbidity.19 Cardiovascular disease, 
diabetes mellitus and hypertension are a few of the more prevalent comorbidities in 
populations with OA.19,24,25 The rationale behind this link may be due to similar risk 
5 
 
factors across the conditions, such as age and obesity and the fact that pain and decreased 
mobility associated with OA limits a person’s ability to self-manage conditions such as 
diabetes and hypertension as it impacts physical activity levels.19,26–29 
Treatment of Knee Osteoarthritis Including Total Knee Arthroplasty 
Osteoarthritis is a progressive disease, but it is most definitely not predictable.  
Systematic reviews and meta-analysis have highlighted prognostic factors that may 
predict the progression of OA.  Patient characteristics included in these predictors were: 
age, varus alignment, presence of OA in multiple joints, radiographic features and body 
mass index (BMI).  Participation in physical activity was not associated with progression 
of OA.30 
Currently, there is no cure for osteoarthritis.  Treatment is targeted at managing 
symptoms, including pain and loss of function.31  
Pharmacological interventions such as acetaminophen, non-steroidal anti-inflammatory 
drugs (NSAIDs) and intra-articular injections have all been found to be superior to 
placebo with respect to decreasing pain and improving function.32 Although these 
treatments may be beneficial in symptom management, the adverse effects associated 
with these interventions are significant.  NSAIDs alone have been shown to increase the 
risk of serious conditions such as peptic ulcer bleeds, cardiac and kidney disease.33–36 
Weight loss has also been determined to be an effective intervention for those with knee 
OA.  A reduction in weight of 5-10% has been associated with a significant decrease in 
pain and disability.37,38 Zheng et al examined the association between an increase in 
weight and risk of OA.  Their systematic review concluded that in an increase in BMI of 
5kg/m translated into a 35% increased risk of developing knee OA.39  
In 2013, Uthman et al., undertook a systematic review and meta-analysis. Their objective 
was “To determine whether there is sufficient evidence to conclude that exercise 
interventions are more effective than no exercise control and to compare the effectiveness 
of different exercise interventions in relieving pain and improving function in patients 
with lower limb osteoarthritis.”   They concluded that enough evidence had been 
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accumulated to show significant benefit of exercise over no exercise in patients with OA.  
The authors also concluded that further studies would unlikely change this result.  
Exercise prescription targeting increase in strength, flexibility and aerobic capacity are 
likely to provide the most effective results.40 
In 2015, Fransen et al., completed a Cochrane systematic review concluding, exercise is 
the only intervention for knee OA whose efficacy is supported by over 50 randomized 
controlled trials and recommended by several best-practice guidelines.41 
Inclusion of neuromuscular exercises into a comprehensive exercise program with the 
goal of improved sensorimotor control and functional stabilization of joints has proven to 
be effective in symptom management in those with OA42.  These exercises involve 
multiple joints and muscle groups and are performed in functional weight bearing 
positions.  Emphasis is placed on quality of movement and alignment during the activity. 
First line and second line treatments including: education, exercise, weight control, 
medication, assistive devices and physiotherapy are all effective management strategies 
for those with knee OA.31,43 For many, this is all that will be required to control 
symptoms and maintain function.  For those who continue to experience significant pain, 
loss of function and decreased quality of life, a total knee replacement can be a beneficial 
and cost-effective treatment for end-stage OA.15 Appropriateness of surgery must take 
into consideration the patient’s current state, disease progression and expected benefit 
from the proposed surgery.   
According to the Canadian Institute for Health Information, more than 70,000 knee 
replacements were performed in Canada in 2017-18.  Approximately 65, 00 were primary 
replacements.  These numbers have increased by 17% in the last 5 years.1 The 25-year 
survivorship for total knee arthroplasty is estimated to be 82%.3 Despite overall 
favourable results many studies estimate that up to 20% of patients are dissatisfied 
following a total knee arthroplasty.  Unfulfilled expectations are strongly associated with 
poor satisfaction.4,5 Identifying gaps in expectations would enable clinicians to provide 
better preoperative education to help patients develop realistic expectations for recovery 
which may improve outcomes.  
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Total Knee Arthroplasty Rehabilitation Research 
Defining optimal rehabilitation following total knee arthroplasty continues to be an 
ongoing challenge for researchers and clinicians alike.  As different measures of outcome 
are utilized; when comparing one treatment protocol to another it can be difficult to 
integrate the results and come to an agreed upon best practice guideline.  Patient factors, 
such as expectations, pre-operative function and comorbidities also need to be considered 
when establishing a treatment plan and delivery of care.  It is reported that functional 
improvements can continue to be observed for up to one year following TKA, however 
many rehabilitation programs do not follow patients past the twelve-week mark.44–46    
Westby et al.,47 led a group of 42 experts, including clinicians, researchers and patients 
through a Delphi process to reach a consensus on best practices for post-acute 
rehabilitation following total knee arthroplasty.  Consensus was reached on 
recommendations such as: patients should be offered structured-post acute rehabilitation, 
the rehabilitation should be offered by trained professionals and care should be under 
direct health professional supervision.  Recommended interventions included: therapeutic 
and functional exercise, gait training, cardiovascular training, thermal modalities, manual 
therapy and patient education.  Consensus was not reached when it came to number of 
weeks of treatment, frequency of visits and overall number of treatment sessions.  It was 
agreed, by 97%, that body structures and function outcomes be routinely assessed.  
Recommendations for appropriate tools to assess these outcomes were also highlighted.  
Timed walk, single leg static balance, repeated stands and timed stair climb were 
included in the performance based outcome measures.  The WOMAC, Lower Extremity 
Functional Scale (LEFS) and Numeric Pain Rating Scale (NPRS) were among the self-
report measures agreed to be the best to use. 
The Rehabilitative Care Alliance in Ontario, funded by the 14 Local Health Integrated 
Networks (LHIN), created a best practice framework outlining recommended ambulatory 
rehabilitation care for patients with primary total knee replacement.  The group advocated 
for rehabilitation to be initiated within 7 days of discharge.  Duration of treatment would 
depend on achievement of goals and plateaus but exercises to achieve range of motion 
(ROM) and function throughout the first 12 weeks following surgery should be provided 
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with a frequency of 2-3 times per week.  It was stated that regarding function, ROM and 
health-related quality of life, group-based therapy models provided similar outcomes to 
1:1 therapy.  In planning for discharge, patients are to be provided with a home program 
and education in a continuing program in the community.  To measure progress, ROM, 
strength and gait speed are to be assessed along with one self-report measure and at least 
one performance-based outcome measure.13  
Buker et al.,48 conducted a prospective randomized trial comparing supervised 
physiotherapy and a standardized home program on functional status in 34 patients 
following a total knee arthroplasty.  The WOMAC was used for assessment of physical 
function.  Secondary measures included pain on a visual analog scale, ROM, Beck 
Depression Inventory Scale and the Short Form 36 (SF36) to assess overall quality of 
life.  The study found no difference between the two groups with respect to functional 
status.  No performance-based measures were included for the assessment of functional 
status. 
Bruun-Olsen et al.,49 conducted a randomized controlled trail (RCT) to compare the 
immediate and long-term  effects of a walking-skill program and usual physiotherapy 
care in 57 patients following primary total knee arthroplasty.  The walking-skill group 
program included functional training in weight-bearing positions and participating in 
activities such as, climbing stairs, walking at different speeds and maneuvering around 
and over obstacles.  The usual physiotherapy care included ROM and strength exercises 
mostly performed in sitting, with little emphasis on a functional component.  Both groups 
received 12 supervised sessions over the course of 6 weeks.  Outcome measures included: 
the 6 minute walk test (6MWT), timed stair climbing, timed stands, figure-of-eight test, 
index of muscle function, active knee ROM, Knee Injury and Osteoarthritis Outcome 
Score and self-efficacy score.  The results reported a significant difference between 
groups favoring the walking-skills group with respect to the primary outcome measure of 
the 6MWT.  This difference was noted at all testing time points which included 9 months 
after the intervention ended, at 12 months following surgery. 
Harmer et al.,50 conducted a RCT comparing land-based versus water-based rehabilitation 
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in 102 patients following total knee arthroplasty.  Groups were compared at 8 and 26 
weeks following surgery using the 6MWT, stair climbing power and WOMAC.  Pain was 
recorded on VAS along with passive knee ROM and knee edema.  All outcomes 
improved in both groups over time.  Although there was a statistically significant 
difference, favouring the water-based group in stair climbing power, WOMAC stiffness, 
WOMAC function and knee edema, these were felt to not be clinically important 
differences.  This would lead us to conclude that both land-based and water-based 
rehabilitation provides comparable improvements following TKA.  
In recent years two systematic reviews have examined exercise after TKA.  In 2013, 
Pozzi et al.,51 published a systematic review of 19 controlled trials identifying four 
categories of post-operative intervention of importance to discuss: strengthening 
exercises, aquatic therapy, balance training and clinical environment.  The authors 
provided recommendations for optimal outpatient physiotherapy protocols based on their 
findings.  Based on the literature it is recommended that strengthening and functional 
exercises, both land-based or water-based are appropriate.  Rehabilitation performed in a 
clinic may provide the best long-term outcomes.  Studies that conclude that outpatient 
physiotherapy does not offer long-term benefit often used inadequate methodology to 
support their results. There was some agreement that alternate forms of rehabilitation, 
such as home based or telerehabilitation can provide improved outcomes for those who 
may not be able to access outpatient rehabilitation facilities.  Consistently it was noted 
that “usual care” or “standard physical therapy” often lacked the detail surrounding 
treatment parameters making it difficult to compare treatment groups.  With each study 
established measures were used to assess change in selected outcomes.  Performance-
based measures such as the timed up and go (TUG), stair climb test, 6MWT, gait speed, 
and 30CST were often used to evaluate functional change.  The WOMAC, Oxford Knee 
Score and SF-36 provided information regarding self-reported change.  
In 2015, Artz et al.,52 completed a systematic review and meta-analysis exploring the 
effectiveness of physiotherapy exercise following total knee replacement.  The review 
included 18 randomized control trials with a total of 1739 patients following TKA.  
Outcomes measures used included both performance-based and self-report measures of 
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function similar to the Pozzi et al.,51 systematic review. Of note, 11 of the 18 RCTs were 
used in both papers.  Results of the meta-analysis were reported as standardized mean 
differences (SMD).  Overall, compared to those receiving minimal physiotherapy, those 
provided with physiotherapy exercises had improved physical function at 3 to 4 months 
with a SMD of -0.37 (95% confidence interval (CI) -0.62 to -0.12) concluding that those 
who received physiotherapy exercises had a greater improvement in physical function 
than those who received minimal or no physiotherapy exercise. 
After review of the literature it is clear that although there are some common themes 
highlighted in research, there is still no clear formula when it comes to rehabilitation 
following TKA.  Patient and environmental factors are essential to consider when 
establishing a treatment plan.   
Many studies have integrated both self-report and performance-based measures into their 
outcomes, including the 30CST and gait speed, allowing them to capture perceived and 
true functional change when comparing groups.  There continues to be a growing body of 
evidence that self-report measures are influenced by the patient’s experience during 
activities, such as increased pain or rate of perceived exertion and therefore can provide 
an imprecise representation of their true functional capacity.53,54 Therefore, in addition to 
self-report measures, performance-based measures are essential to use when measuring 
functional improvement following TKA.8,9,53,55 
Measurement Properties 
When selecting outcome measures to evaluate functional change, it is crucial that the 
measure possess adequate measurement properties.  Acceptable reliability, validity and 
ability to detect change are required in order to provide accurate and meaningful results.  
To be useful outcome measures should allow for improvement and deterioration in a 
patient’s functional status to be revealed.56  
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Reliability 
A reliable measure must possess precision, or the ability to provide consistent values for 
repeated measurements with minimal error in measurement.  It must also be able to 
differentiate between individuals who are being measured with the tool.  With this in 
mind reliability is often communicated as relative reliability or absolute reliability. 
Relative reliability allows us to explore the measure’s ability to differentiate between 
individuals. Relative reliability is calculated as the ratio of the true variance to the total 
variance.  The true variance can also be termed as between-patient variance.  The total 
variance is the sum of the true variance and the error variance, or within-patient 
difference.56 Relative reliability is expressed with an Intraclass Correlation Coefficient 
(ICC) with values varying from 0.00-1.00.  An ICC closer to 1.00 indicates higher 
reliability.  Portney and Watkins suggest that values less than 0.50 reflect poor reliability, 
0.50 to 0.75 suggest moderate reliability and ICC values greater than 0.75 reflect good 
reliability.57 Similarly, Fleiss describes values from 0.40 to 0.75 as fair to good.58 When 
evaluating relative reliability the ICC is the superior coefficient to use rather than Pearson 
product moment correlation.  Association between two sets of data determines 
correlation.  Pearson’s can tell us how the scores vary together, but does not provide 
information on the agreement between the score.56   
Absolute reliability interprets the error associated with an individual’s score at a single 
point in time.  The measurement error is reported in the same units as the original 
measurement unlike the ICC.  This is often expressed as the standard error of 
measurement (SEM).  The SEM is calculated as standard deviation(SD)√ (1-ICC).  In 
order to establish if true change has occurred in a score rather than change due to error in 
measurement the Minimal Detectable Change (MDC) can be calculated using the SEM. 
Calculating an estimate of the Minimal Detectable Change at 90% confidence level 
(MDC90) is achieved by multiplying the SEM by √2 and the z value for 90% confidence 
(1.64).57 
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Validity 
Validity refers to the extent that a measure actually measures what it is intended to 
measure.  A valid measure also allows us to make inferences from test scores that may 
assist us in clinical decision-making.  Portney and Watkins state that a measure may be 
used for discriminative, evaluative or predictive purposes.  Is the measure able to 
discriminate among individuals with and without a condition or trait? Can the measure 
evaluate change between two test occasions? Finally, can we make predictions 
surrounding prognosis or function based on a measures score?  These are related to the 
validity of a measure.57 
When examining validity, the magnitude and direction of the relationship between two 
measures is often studied using correlation analysis.  When evaluating continuous 
interval or ratio data the most common measure of correlation is the Pearson product 
moment correlation (r).  If the data being analyzed is ranked or ordinal a Spearman rank 
correlation co-efficient is used (rs).  Correlation values are reported from 0.00 (no 
correlation) to 1.00 (perfect correlation).57 Portney and Watkins suggest, “correlations 
ranging from 0.00 to 0.25 suggest little or no relationship; those from 0.25 to 0.50 
suggest a fair degree of relationship; values of 0.50 to 0.75 are moderate to good; and 
values above 0.75 are considered good to excellent”.57 The direction of the relationship 
between the two measures will be represented by a + or - sign.  For example, if one 
variable increases as does the other a positive (+) correlation occurs.  If one variable 
increases while the other decreases a negative (-) correlation will be reported. 
Four types of validity are described in the literature: face validity, content validity, 
criterion validity and construct validity.56 
Face validity indicates that a test appears to test what it is supposed to.  This is the least 
rigorous form of validity and is often established through observation. 
Content validity refers to the extent that the measure incorporates a comprehensive 
sample of items with respect to what is being evaluated.  For example, if lower extremity 
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function is the topic of interest, the measure should encompass multiple tasks that relate 
to the lower extremity. 
Criterion validity is the most objective approach to validity.  It examines the measure’s 
ability to predict results obtained using another measure.  The measure being examined is 
compared to a gold standard or established measure that is already validated.  The scores 
on the two measures can then be correlated to each other to determine if the new measure 
could be used as an alternate for the other validated measure it is tested against.  Criterion 
validity can be divided into concurrent validity and predictive validity. Concurrent 
validity is studied when the two measures are administered at approximately the same 
time.  Prescriptive validity evaluates a measure’s ability to predict a future criterion score 
or outcome. 
Construct validity is applied in the absence of a gold standard.  Here theories are 
formulated and validity is evaluated based on the extent to which the measure produces 
results in line with the proposed theories.  Within the confines of construct validity also 
discussed is cross-sectional and longitudinal validity, convergent and discriminant 
validity, known-groups validity, sensitivity to change and responsiveness. 
Cross-sectional validity48 evaluates two measures administered at a single point in time 
and the association, or correlation between the scores on that one occasion.  Longitudinal 
validity examines the association between the change score of the validated measure and 
the change score of the new measure being studied.  Convergent validity indicates that 
two measures that are thought to test the same thing should provide similar results and be 
highly correlated.  Measures that test different attributes should yield low correlation or 
different results indicating adequate discriminant validity.  Known-groups validity 
examines two or more distinct groups.  It is anticipated that the measure will be able to 
distinguish between groups that possess a certain attribute or level of attribute. 
Longitudinal validity describes the extent to which a measure evaluates constructs related 
to change. Sensitivity to change is the often simply referred to as the ability of a measure 
to detect change over time.  Coefficients used to express sensitivity to change can include 
Effect Size (ES) and Standardized Response Mean (SRM).  ES is calculated by dividing 
14 
 
the mean change score by the standard deviation of the baseline score.  Cohen describes 
interpretations of ES as scores below 0.2 are small, 0.5 is considered moderate and 0.8 is 
considered large.56 SRM is calculated by dividing the mean change by the standard 
deviation of the change scores. A SRM > 1 indicates that the change could be detected 
over the variability.56 Responsiveness is the ability of a measure to detect clinically 
meaningful change over time.  Liang states “sensitivity to change is a necessary but 
insufficient condition for responsiveness”.  What constitutes a clinically important 
change can vary depending on the situation and the interpretation of the individual.59 
Standardized Performance-Based Outcome Measures used in Total Knee Arthroplasty 
Performance-based outcome measures play an important role in measuring functional 
change and outcome following TKA.  The relationship between a patient’s self-efficacy 
in performance of function and these measures is strong and mitigates the individual’s 
inability to discriminate between pain and their ability to perform the task that can often 
be associated with self-report measures of function.9,53,60 
Recommended performance-based measures to assess function in people with hip and 
knee osteoarthritis, those awaiting joint replacement and following joint replacement 
have been outlined by various groups such as The Osteoarthritis Research Society 
International (OARSI), Rehabilitative Care Alliance (RCA) and various clinical 
researchers.11–13 Although the recommended measures may vary slightly from group to 
group, they often include a measure of gait speed and lower extremity functional strength 
and endurance integrated into typical activities relevant to the patient population such as 
climbing stairs, getting in and out of a chair and walking. 
Groups such as OARSI and the RCA, recommend a minimum set of self-reported 
outcome measures and PBOM. These measures focus on a population diagnosed with 
osteoarthritis (OA), as well as those following joint replacement.  Although the 
psychometric properties of these measures have been evaluated extensively in those with 
knee OA who may be awaiting TKA, to our knowledge, the reliability and validity has 
not been examined in the TKA population during postoperative rehabilitation. 
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Dobson et al12 proposed a recommended set of performance-based measures to use in 
people diagnosed with hip and knee osteoarthritis or following joint replacement.  A 
survey of experts and systematic review facilitated the process and measures were 
selected based on their measurement-property evidence, feasibility of the test, scoring 
method and expert consensus.  This process resulted in a recommended set of 
performance-based measures including: the 30CST, 40 m Fast-paced Walk Test 
(40FPWT), Stair Climb Test, TUG and 6 Minute Walk Test (6MWT).  The first three of 
the mentioned tests were recommended as a minimum core set.  As a follow up to these 
recommendations, due to the complex nature administering the 40FPWT and scoring the 
11 Step Stair Climb Test, the 10 Metre Fast-paced Walk Test and 20-second stair climb 
test were suggested as alternatives.61 
The Total Joint Arthroplasty and Outcome Measures (TJAOM) Knowledge Translation 
Taskforce, led by Dr. Marie Westby, has created a toolkit to provide clinicians with 
outcome measures for use along the continuum of care for patients before and after 
arthroplasty.11 Prior to the creation of this toolkit McAuley et al.,62 surveyed Canadian 
Physiotherapists about their experience using outcome measures in total hip and knee 
arthroplasty patients.  Familiarity with tests, current use and potential for future use were 
explored.  A secondary aim of the study was to understand clinical issues and barriers to 
using outcome measures in various practice settings. A majority of the respondents 
reported using more than one outcome measure.  Familiarity was greatest with the TUG, 
Single Leg Stance Test and 6MWT followed by the Sit to Stand Test and Walking Speed 
Test.  Beliefs regarding value of using a standardized tool, varying patient populations, 
phase of recovery, care setting and availability of tools were all noted as concerns and 
potential barriers to implementing appropriate outcome measures into their current 
practice. 
The recommendations outlined in the TJAOM tool kit included outcome measures to be 
used along the total joint arthroplasty continuum: Pre-operative, Acute, Post-acute and 
Active Living.  Pre-operative was defined as moderate to advanced OA.  Acute is during 
the hospital stay. Post-acute refers to the outpatient/home therapy setting and active 
living would be defined as 1 year following surgery and onwards.  With the exception of 
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the acute phase, the recommended performance-based outcome measure included: 
30CST, Gait speed (self-selected), Stair climb test, Single leg stance test (30 seconds), 
6MWT, TUG and functional reach. 
Sit to stand and walking tests have been used and are recommended to measure 
performance in both patients with OA who may be awaiting joint replacement and those 
following joint replacement surgery.9,53,63,64 Not only can these measures be used to track 
progress with functional change, they may also assist in clinical decision making, goal 
setting and communication with both patients and other health care providers.62 
Reliability of Sit to Stand Test/Walk Tests 
Gill et al.,63 investigated the intra-rater and inter-rater reliability of the 50-foot Timed 
Walk (50FTW) and 30CST in patients awaiting total hip or total knee replacement.  
Eighty-two subjects who were participating in a 6-week exercise program were recruited.  
Measurements were collected at baseline, 7 weeks and 15 weeks.  During each testing 
occasion, four trials of the 50FWT and two trials of the 30CST were completed, as the 
30CST may be more likely to exacerbate pain.  The study also explored if a practice 
effect may be responsible for improved performance.  ICC (1,1) was calculated for each 
testing occasion and resulted in ICCs for the 50FTW ranging from 0.93 (95%CI 0.91 to 
0.96) to 0.97 (95%CI 0.96 to 0.98).  The SEM was 1.32 seconds and the MDC90% was 
calculated to be 3.08 seconds.  These were calculated from the baseline assessment 
scores. It was noted by comparing mean scores that the first trial of the 50FWT was 
slower than subsequent trials. Results were similar for the 30CST with results ranging 
from 0.95 (95%CI 0.93 to 0.97) to 0.98 (95%CI 0.97 to 0.99).  For baseline scores the 
SEM was 0.70 stands and the MDC90% was 1.64 stands.  As the SEM and MDC90% 
were calculated from baseline scores, we are unaware if these are similar when repeated 
after an intervention has taken place. The authors concluded that the 50FWT and the 
30CST could be reliable measures in those awaiting joint replacement.  They did note 
that a practice trial should be administered when first introducing the test as significant 
differences were noted between trial one and trial two. These stabilized for the remainder 
of the 50FWT trials, but we are unsure if the same would hold true for the 30CST as only 
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two trials were completed due to concerns of increasing pain.  The protocols described in 
this study were used in the study completed for this thesis. 
Fransen et al.,65 examined 41 patients with knee osteoarthritis.  Each patient performed a 
walk test over a course of 8 metres.  Five trials were completed at a self-selected pace 
that individuals considered normal, followed by five trials at a self-selected pace that 
individuals considered fast.  A rest period of 45-60 seconds was provided between each 
trial.  A total of three test occasions were completed at one week intervals.  Results 
showed that the ICC (2,1) were consistently high ranging from 0.90 to 0.98 with the 
lower boundaries of the 95%CI ranging from 0.84 to 0.96.  The authors noted superior 
test-retest reliability in the fast-self-selected walking speed as compared to the normal 
self-selected speed.  The SEM 90%CI was calculated as +/-0.12 m/s. Similar to other 
studies they noted that there was a learning curve and a practice trial allows for 
familiarization where stability between the second and third trials was achieved.  
Kennedy et al.,55 examined the reliability and sensitivity to change of the 6MWT, TUG, 
Stair Climb Test and a Fast Self-Paced Walk Test (SPWT) in patients with hip and knee 
osteoarthritis who went on to have a total hip or total knee arthroplasty.  Test-retest 
reliability (ICC (2,1)) was assessed in 21 patients at three time points prior to surgery.  
Subjects were required to walk two lengths of a 20 metre course (excluding turns) and 
given the instruction “walk as quickly as you can without overexerting yourself”.  The 
median time between the first and second test occasions was 91 days and between the 
first and third test occasions was 178 days.  The authors felt that time between testing 
sessions was acceptable to establish test-retest reliability as previous literature had 
suggested that the amount of functional change while someone was on the waitlist is 
minimal.  The estimated reliability was calculated as ICC = 0.91 (95%CI 0.81 to 0.97), 
SEM 1.73 (95%CI 1.39 to 2.29) confidence in score 90% = +/- 2.86sec and MDC90% = 
4.04 seconds.  In conclusion, the authors felt that the measure met the requisite standards 
for acceptable reliability for making decisions at the individual patient levels. It must be 
noted that no test-retest reliability analysis was completed following surgery and the 
sample size used for the analysis was quite small.  Responsiveness of the measure will be 
discussed in a future section. 
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Perera et al.,66 examined 692 participants enrolled in three different studies.  The three 
data sets were used and analyzed. Gait speed was calculated in meters/second and 
distance covered in the different studies ranged from 10 feet to 10 metres.  Test-retest 
reliability estimates were calculated from a subsample of subjects from the studies and 
used to calculate the SEM.  ICC values were not reported.  SEM results varied from 
0.04m/s for a 10 metre distance to 0.10 m/s for a distance of 10 feet.  Meaningful change 
was then estimated using both an anchor-based and distribution-based method.  The 
overall recommendations outlined a change of 0.05 m/s and 0.10 m/s were required to 
meet a small and substantial meaningful change with a 10 m gait speed test. 
Barthuly et al.,67 highlighted that restoration of walking is a primary concern for those 
undergoing short-term rehabilitation.  Relevance to community ambulation, incident 
health events and mortality has led many to recommend gait speed as a clinical vital sign.  
136 patients admitted for short-term rehabilitation participated in a prospective 
observational study.  Participants were tested on admission, the following day and prior 
to discharge (mean of 15.1 days).  Gait speed was assessed over a 5.2 m course with time 
beginning after a 1 m distance allotted for acceleration.  ICC was estimated at 0.932 
(95%CI 0.906 to 0.951).  The SEM was calculated as 0.05 m/s and the associated 
MDC95% was 0.13 m/s.  The authors concluded that results were consistent with 
previous studies. 
Davey et al.,68 looked to estimate the test-retest reliability of a number of functional and 
self-report measures in 21 elderly subjects with hip and knee osteoarthritis.  The 
participants were part of a larger RCT to determine the cost-effectiveness of water 
therapy for those with OA.  The walking test required subjects to ambulate over a 
distance of 8 feet with an additional 2 feet at either end.  Individuals were asked to walk 
“at their own pace”.  Two trials were allowed with the faster of the two being noted.  The 
measures were repeated on two occasions less than a week apart.  The study looked to 
estimate test-retest reliability to determine the degree to which the same result can be 
obtained with repeat measurements.  The SEM was estimated to provide information as 
to how useful a measure may be for monitoring change in performance and the variation 
that might be expected for a measure.  Test-retest correlations were estimated using 
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Pearson’s correlation co-efficient and reported as r = 0.90. SEM was reported as 0.12 
seconds (95%CI -0.07 to 0.29).  MDC90% was not reported.  One concern is using 
Pearson coefficient rather than an Interclass Correlation Coefficient to estimate 
reliability.  As mentioned previously, Pearson does not take differences between score 
into account, only how they vary to each other.  This may lead to an overestimation of 
agreement. 
Dobson et al.,61 set out to evaluate the reliability and measurement error of the OARSI 
recommended performance-based tests of physical function in 51 people with hip and 
knee osteoarthritis.  The performance-based measures included the 40FPWT, 10FPWT 
and 30CST.  Relative reliability was calculated using ICCs and absolute reliability was 
estimated using SEM and MDC.  Participants completed the measures on two test 
occasions, one-week apart.  Within-rater reliability was calculated using an ICC (2,1) and 
between-rater using an ICC (1,1).   
For the 40FPWT the ICC (1,1) for the 40FPWT was 0.96 (95%CI 0.93 to 0.98) and SEM 
0.06 m/s (95%CI 0.05 to 0.08).  The ICC (2,1) was estimated as 0.92 (95%CI 0.82 to 
0.96) and SEM 0.07 m/s (95%CI 0.06 to 0.09).  MDC90% was estimated as 0.19 m/s. 
Results for the 10FPWT ICC (1,1) was 0.91 (95%CI 0.83 to 0.95) and ICC (2,1) was 0.88 
(95%CI 0.80 to 0.93).  SEM was 0.10 m/s (95%CI 0.09 to 0.13). MDC90% was 
estimated as 0.28 m/s. The 30CST measured in number of stands was estimated as 0.86 
(95%CI 0.77 to 0.92) with an SEM of 1.0 (95%CI 0.8 to 1.3) and within-rater as 0.85 
(95%CI 0.67 to 0.93) with an SEM of 0.9 (95%CI 0.7 to 1.1).  MDC90% was estimated 
at 2.0 stands. 
The authors concluded that sufficiently small measurement error associated with the tests 
indicate these tests are appropriate for measuring change in those with hip and knee OA.  
The results also indicate that the 10FPWT is an acceptable alternative to the 40FPWT. 
Marks,69 evaluated the reliability of the 13 m walk test in 15 females with knee OA.  
Subjects completed two trials of the test with a 2 minute rest period in between.  The 
same protocol was carried out 1 week later with no intervention in between. Results 
concluded ICCs for the tests conducted within and across sessions were 0.98, 0.99, 0.88 
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and 0.80, respectively.  95%CI was not reported.  The average SEM across sessions was 
1.06 seconds.  MDC 90% was not reported.  In contrast to other studies, Marks reported 
that there were no systematic learning curve or fatigue effects with repeated testing.  The 
author did admit that a larger sample size would be ideal in further studies. 
Jones et al.,70 evaluated the 30CST as a measure of lower body strength in community-
residing older adults.  76 community-dwelling older adults completed two 30CST and 
two maximum leg-press tests; these were repeated 2 to 5 days later.  The authors were 
interested in the 30CST as an alternative to other sit to stand tests that required an 
individual to complete a minimum amount of sit to stands.  It was observed that a number 
of older adults could not complete the minimum number of stands required for the test, 
which resulted in a floor effect.  A floor effect results when a subject cannot reach the 
minimum requirements of a test.71,72  Test-retest ICC for the 30CST was estimated at 0.89 
(95%CI 0.79-0.93).  The authors noted that all participants were able to complete the 
30CST with scores ranging from 2 to a maximum of 21.  They concluded that the 30CST 
had the capability of assessing a wider range of ability levels and did not demonstrate the 
same floor effect that other tests that required a minimum number of stands had 
previously in the literature. 
Wright et al.,73 assessed patients with a diagnosis of hip or knee OA, who were part of a 
larger trial, in an effort to estimate reliability of the 40FPWT, TUG, 30CST and 20-cm 
Step Test.  Two different raters tested participants, one week apart, prior to any 
intervention.  ICC (2,1) was calculated for the 40FPWT as 0.95 (95%CI 0.90 to 0.98) 
with an SEM of 1.00 m/s. The ICC for the 30CST was estimated as 0.81 (95%CI 0.63 to 
0.91) with a SEM of 1.27 stands.  The authors indicated that 33 patients were required for 
the reliability assessment.  Unfortunately, this was not achieved and may have impacted 
the significance of the results. 
Tolk et al.,74 conducted a prospective cohort study to investigate the reliability, validity 
and responsiveness of the OARSI core set of performance-based outcome measures that 
include the 30CST, 40FPWT and Stair Climb Test.  Participants included 85 patients 
with knee OA who were awaiting TKA.  Measures were collected pre-operatively and 12 
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months following surgery.  Test-retest calculations were obtained pre-operatively with a 
30-minute rest period between testing sessions.  Appropriate test-retest reliability was 
found for all three tests.  For the 30 CST an estimated ICC of 0.90 (95%CI 0.68 to 0.96), 
SEM 0.85 stands and smallest detectable change (SDC = 1.96 x √2 x SEM) of 2.4 stands 
was reported.  The 40FPWT yielded a similar ICC of 0.93 (95%CI 0.85 to 0.96), SEM 
0.10 m/s and SDC of 0.27 m/s.   
Reliability of Performance-Based Outcome Measures in rehabilitation following TKA 
The relative and absolute reliability of sit to stand and walk tests has been established for 
a number of different types of tests and suggests good to excellent reliability.  When 
exploring reliability of these performance-based outcome measures, many studies have 
included patients with hip and knee OA who may or may not be awaiting total joint 
arthroplasty.  Those studies that included patients who underwent TKA calculated 
reliability in testing sessions that occurred prior to surgery.  To our knowledge, there are 
no reports to date of relative or absolute reliability estimates calculated during 
rehabilitation following TKA.  As well, the MDC90% that has been reported has been at 
a single time point prior to surgery.  In order to accurately estimate the relative and 
absolute reliability, along with the MDC90% at various time points in rehabilitation 
following TKA these performance-based outcome measures need to be examined in the 
desired population at the appropriate time points following surgery. 
Validity of Sit to Stand/Walk Test 
Using a head-to-head comparison design, Gill et al.,64 assessed and compared the validity 
of six physical function measures in 82 people awaiting TKA or THA.  The measures 
examined included the WOMAC physical function (WOMACpf) scale, SF-36 Physical 
Component Summary Scale, Patient Specific Functional Scale, 30CST and 50-foot timed 
walk.  Validity was explored by assessing convergent validity, discriminative validity, 
known-groups validity and responsiveness.  Spearman’s rho correlation coefficients were 
calculated when investigating convergent and discriminative validity.  The 30CST had 
moderately high correlations with the 50-foot walk test (ρ = 0.64) and WOMACpf (ρ = 
0.62).  The correlation between the 50-foot walk test and WOMACpf was moderately 
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correlated (ρ = 0.42).  All three of the mentioned tests had evidence of known-groups 
validity and were able to distinguish between subjects who were using a gait aid and 
those who were not.  Standardized response means (SRM) of 0.2, 0.5 and 0.8 have been 
interpreted to represent small, moderate and large responsiveness to change.75  The 
30CST had large responsiveness (0.84, 95%CI 0.61 to 1.07) while the 50-foot walk test 
(0.45, 95%CI 0.22 to 0.68) and WOMACpf (0.70, 95%CI 0.47 to 0.93) had a more 
moderate response. 
Jones et al.,70 conducted a study to examine the validity of the 30CST as a measure of 
lower body strength in adults over the age of 60.  A moderately high correlation was 
found between the 30CST and weight-adjusted leg press (r = 0.77, 95%CI 0.64 to 0.85).  
It was also observed that the 30CST could discriminate between age groups and levels of 
physical activity. 
Wright et al.,73 compared three methodological approaches to establishing the major 
clinically important improvement (MCII) of four tests, including the 30CST and 
40SPWT.  Three anchor-based approaches were used in patients with hip OA.  An 
anchor-based approach compares changes in the outcome measures’ score to an external 
standard; often used is the Global Rating of Change (GRC).  The authors selected a GRC 
score of greater than +5 to represent an important change.  Patients who indicated a major 
improvement had statistically significant greater improvements in the 40 SPWT and 
30CST.  When comparing the three methodological approaches, the MCII for the 30CST 
varied from 2.0 to 2.6 stands and the 40SPWT from 0.2 to 0.3 m/s. 
French et al.,76 conducted a study to compare the responsiveness of two self-report 
measures and three performance-based measures in patients with knee OA after 
physiotherapy.  Both the WOMAC and timed-stand-test were included in their 
investigation.  The timed-stand-test change score was significantly different (p<0.002) 
indicating the result of the outcome was different following intervention.  An SRM of 
0.39 and ES of 0.36 demonstrated a small effect size based on Cohen’s criteria. 
Marks,69 conducted an observational study to investigate the validity of the 13-m walk 
test in 15 patients with knee OA.  A positive correlation (r = 0.66) was found between the 
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walk test and the functional handicap scores on the Lequesne Index of Severity for Knee 
OA.  No relationship was identified between the walk test and age, weight or height. 
In 2003, Stratford et al.,77 conducted an observational study of 93 patients awaiting total 
hip or knee arthroplasty.  The authors explored the correlation between the Lower 
Extremity Functional Scale (LEFS), the self-paced walk test (SPW) (2 lengths of a 20m 
indoor course), TUG and stair test.  A significant correlation was reported between the 
LEFS and self-paced walk test (r = 0.44, 95%CI 0.26 to 0.59).  To further investigate the 
content validity of the timed tests, the LEFS walk items were correlated with the SPW.  
This yielded similar results r = 0.47 (95%CI 0.29 to 0.61).  Performance-based measure 
outcomes are reported in time and do not take into account pain or perceived exertion.  
Following the completion of the performance-based measure, participants were asked to 
rate their pain when performing the test and their rate of perceived exertion.  When the 
time, pain and exertion scores were pooled for the SPW test, the correlation with the 
LEFS was significantly greater, r = 0.59 (95%CI 0.44 to 0.71).  The authors concluded 
that adding pain and exertion domains would heighten the content validity of the 
performance-based test. 
Kennedy et al.,55 conducted an observational evaluating the sensitivity to change of four 
performance-based measures following total hip and knee arthroplasty.  Two time points 
following surgery were to be explored to assess the ability of the measures to detect 
change, both deterioration and improvement.  Participants were evaluated pre-
operatively, within 15 days post-operatively and a minimum of 20 days occurred between 
the second and third testing session.  SRM for the self-paced walk test was estimated at -
0.89 (95%CI -1.42 to -0.68) between the pre-operative and first post-operative testing 
session.  The negative score was associated with deterioration in function, which would 
be expected so soon after surgery.  The SRM during the post-operative phase was 
reported as 0.79 (95%CI 0.66 to 1.45). 
Barthuly et al.,67 conducted a prospective observational study involving patients admitted 
to short-term rehabilitation following an acute-care hospitalization.  The majority of 
subjects had undergone total knee arthroplasty.  Gait speed was measured at a 
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comfortable speed over 5.2 m and measured at baseline, 2 days later and just prior to 
discharge. The mean time between admission and discharge was 15.1 days.  ES 
estimation for gait speed was 1.11 and SRM was 1.25.  Minimal clinically important 
difference (MCID) was also explored and was reported between 0.10 m/s and 0.18 m/s 
depending on the anchor used to establish significant change. 
Borjesson et al.,78 set out to identify the most discriminative walking speed to be used 
when evaluating patients with knee osteoarthritis following unicompartmental knee 
arthroplasty or high tibial osteotomy.  54 individuals walked a 5 m distance, with 3 m of 
walkway at each end to allow for acceleration and deceleration.  The distance was 
completed with walks at slow, normal and fast speeds.  The first test occasion occurred 
prior to surgery and the second, one-year following surgery.  During each testing session, 
two trials were completed with the second trial used for the calculation. Responsiveness 
was calculated as ES, SRM and relative efficiency.  Relative efficiency was estimated 
with t-statisticfastpace/t-statisticnormalpace). All subjects with unilateral knee OA had a 
significant ( p<0.001) improvement in their walking speed from pre-surgery to post-
surgery.  ES ranged from 0.34 to 0.58 and SRM varied from 0.49 to 0.71.  For both ES 
and SRM the slow walking had the highest values.   
Tolk et al., examined the construct validity and responsiveness of the OARSI core set of 
performance-based outcome measures.74  Creating predefined hypotheses assessed both 
properties.  Measures would be assumed valid and responsive if at least 75% of the 
hypotheses were confirmed.  Based on this evaluation procedure it was determined that 
none of the tests met the construct validity criteria and only the 40FPWT was considered 
to be responsive.  When reviewing each hypothesis, it is observed that correlation 
between the performance-based and self-report measures varied between -0.25 and 0.35.  
Change scores and analysis of responsiveness between the anchor-question using a GRC 
and the change score on the self-report-measure of function ranged between -0.22 and 
0.43.  The authors concluded that the performance-based measures were not valid or 
responsive and therefore do not justify their use in clinical practice. A statement like this 
needs careful consideration, as it was the predefined hypotheses that determined the 
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validity and responsiveness.  Had other parameters been used the results and conclusion 
may have differed greatly. 
Validity of Performance-Based Outcome Measures in rehabilitation following TKA 
It appears that there is at best a moderate association between self-report and 
performance-based measures, including sit to stand and walk tests.  The two can be 
considered complementary, but do not measure the same construct.  Stratford et al54 
concluded that performance-based measures may be more sensitive to change than self-
report measures.  Based on the above literature review, it also appears that inquiry into 
the psychometric properties of sit to stand and walk tests has not been evaluated 
previously in post-operative arthroplasty populations (i.e., TKA and THA). Furthermore, 
to our knowledge, previous studies have not investigated the longitudinal and concurrent 
validity of the 30CST and 10MWT during rehabilitation following TKA.  As previously 
mentioned, it has been recommended that these outcome measures should be used in 
clinical practice7,9,11,12,62, and thus requires normative data to ensure optimization of 
clinical outcomes. Normative data has been established for the 30CST and 10MWT in 
community dwelling adult populations,70,79,80  and could provide a benchmark for 
recovery from arthroplasty procedures. Establishing these measurement properties in this 
population is essential to help determine functional change and may assist in identifying 
superior treatment pathways. 
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Chapter 3 
Methods 
Study Design 
The study design was prospective and observational with repeated measures.  Patients 
performed the 30CST and 10MWT and completed the WOMAC and the Global Rating 
of Change (GRC) questionnaires on three occasions.  The initial testing occasion was 
during their initial assessment at the LHSC-UH Physiotherapy Clinic (approximately four 
weeks following surgery).  The second and third occasions were at six weeks and twelve 
weeks following surgery respectively.  This was the usual standard of care for all TKA 
patients referred to our facility.  From these time points we were able to evaluate 
longitudinal validity.  In order to evaluate test-retest reliability, a subgroup of patients 
completed one or two additional testing session and repeated the two PBOMs 24 to 48 
hours following their six-week and twelve-week postoperative testing (Figure 1).  
Participants 
We recruited patients between the ages of 45 and 88 years.  All patients had undergone a 
unilateral primary total knee arthroplasty (TKA) resulting from end stage osteoarthritis 
(OA) as determined by the treating surgeon at London Health Sciences Centre – 
University Hospital (LHSC-UH).  All patients were recruited from the Physiotherapy 
Clinic at LHSC-UH.   
Patients were excluded if they had undergone a revision TKA, bilateral TKA or 
unicompartmental TKA.  Patients with rheumatoid arthritis, diagnosed neurological 
movement disorder or concurrent musculoskeletal condition (e.g. back, hip or ankle 
injury) leaving them unable to complete performance-based outcome measures (PBOM), 
were also excluded.  Patients were required to understand, read and write in English to 
complete study questionnaires.  The institution’s ethics board review board approved the 
study and all participants provided informed consent prior to participation.  The study 
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Figure 1 - Schematic Diagram of Study Design 
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Letter of Information and Ethics Approval Notice are provided in Appendices A and G 
respectively.   
Sample size was based on our primary responsiveness analysis which calculated the 
correlation between the GRC and the two PBOMs as this required the largest sample size.  
Considering an alpha of  = 0.05 and an expected Pearson’s r of 0.6 with a 95% CI width 
of 0.3, we required a minimum sample size of 74 patients with complete data.81  In order 
to account for a potential loss to follow-up rate of 20% we planned to recruit 89 patients.  
We ensured that at least 30 patients participated in the reliability testing, providing the 
ability to estimate an ICC of at least 0.85 with 95% CI width of 0.2.82 
Testing Procedures 
The testing procedures were identical on each test session. LHSC-UH Physiotherapy 
Clinic clinical staff administered testing.  All staff received training on test administration 
and utilized identical protocols and equipment.  The primary study assessor assessed 
them for competency. 
On the initial test occasion, the investigator collected demographic data from the patients 
and entered it into the data collection form (Appendix B).  On the three standard test 
occasions, patients completed the Western Ontario and McMaster Universities 
Osteoarthritis Index (Appendix D), a condition-specific self-report questionnaire 
designed for patients with hip and knee OA. The questionnaire consists of 24 questions 
across three categories: pain, stiffness and physical function.  Individuals are asked to 
rate their level of difficulty on a five-point scale with 0 = None, and 4 = Extremely.  The 
total score is out of 96, with higher scores indicating greater difficulty.  The WOMAC’s 
reliability and validity are well established in hip and knee OA.83  Subsequent to the 
initial test occasion, patients also completed two GRC questionnaires.  The GRC scale is 
used to quantify a patient’s improvement or deterioration over time.84 Patients were asked 
two questions, “With respect to your joint replacement surgery, how would you rate your 
pain (1) or function (2) now, compared to when you first started physiotherapy here at 
University Hospital?”  The GRC utilized in this study was a 15-point adjectival scale 
ranging from -7 (a very great deal worse) to +7 (a very great deal better).  A score of 0 
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indicates the same, or no change.  Other responses were scored as follows: a tiny bit 
better/worse, almost the same = 1; a little bit better/worse = 2; somewhat better/worse = 
3, moderately better/worse = 4; a good deal better/worse = 5; a great deal better/worse = 
6; a very great deal better/worse = 7 (Appendices E and F).  The test administrator also 
measured active knee range of motion and recorded if a gait aid was required during each 
testing occasion. 
The two PBOM were administered according to adapted protocols outlined by Gill et al.63 
and Tilson et al.85 The tests included the 10 Metre Walk Test (10MWT) and the 30 Chair 
Stand Test (30CST).  Each patient completed the WOMAC and GRC prior to the 
PBOMs.  The two PBOMs were completed in the same order, as listed above, at each test 
occasion. 
The 10MWT required the subject to walk as fast as they can, safely, over a total distance 
of 14 metres.  The walking course was set up in a hallway and included a 2 m distance at 
the beginning and end to allow for warm up and slow down. The 10 m in between was 
used for the speed measurement. Subjects were allowed to use their appropriate gait aid, 
which the assessor noted.  Two trials were conducted, with a short rest period between as 
required (Appendix C). 
The 30CST was performed following the 10MWT.  A chair with a 17-inch seat height 
and no armrests was placed against the wall.  Patients were instructed to stand fully up 
and fully down without using their hands and were given 30 seconds to complete as many 
repetitions as possible.  Each subject was allowed one trial sit to stand prior to the test 
beginning (Appendix C).  The same stopwatch was used for both tests and during all test 
occasions. 
Data Analysis 
 
All statistics were calculated using IBM SPSS Statistics version 25.  Descriptive 
statistics, including mean and standard deviation of the sample were calculated.  On each 
test occasion, the 10MWT scores were recorded in absolute time (in seconds) and were 
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calculated as the mean of the two-recorded trials.  The 30CST scores were recorded as an 
absolute number. 
Objective 1 – Test-retest Reliability 
10MWT and 30CST scores from occasions: 2 and 3, and, 4 and 5 were compared using a 
series of paired t-tests.   
 
Test-retest reliability was assessed using values obtained from test occasions 2 and 3 (6 
weeks postoperatively) and test occasions 4 and 5 (12 weeks postoperatively).  Relative 
reliability was estimated using Intraclass Correlation Coefficients (ICC) with a two-way 
random model for consistency.  Absolute reliability was estimated using the Standard 
Error of Measurement (SEM).  SEM was calculated as the standard deviation (SD)√(1-
ICC).  The SEM was also used to calculate an estimate of the Minimal Detectable 
Change at 90% confidence level (MDC90), by multiplying the SEM by √2 and the z 
value for 90% confidence (1.64).  Lastly, we created Bland and Altman plots for the two 
performance-based outcome measures at both 6 and 12 weeks postoperatively (Figures 3-
6). 
Objective 2 – Longitudinal Validity 
Longitudinal validity and sensitivity to change were evaluated using the change scores 
between test occasions: 1 and 2 (initial to 6 weeks postoperative), 1 and 4 (initial to 12 
weeks postoperative) and 2 and 4 (6 weeks postoperative to 12 weeks postoperative).   
 
Pearson correlation coefficients (r) were used to determine the association between the 
change in each performance-based measure, the GRC pain and function, and change in 
WOMAC physical function subscale.   
 
The ability to detect change was expressed by calculating both the standardized response 
mean (SRM) and effect size (ES).  The SRM was calculated by dividing the mean of the 
change scores by the standard deviation of the change scores. The ES was calculated by 
dividing the mean of the change scores by the standard deviation of the baseline score.  
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Specifically, when calculating the ES for initial to 6 weeks post-op and initial to 12 
weeks post-op, the SD from the initial score was used. When calculating the ES from 6-
12 weeks post op, the SD of the score at 6-weeks was used.  These values assist in 
evaluating how well a measure can distinguish “signal” from “noise”. 
 
Objective 3 – Concurrent Validity 
In order to explore concurrent validity of the 10MWT, 30CST and WOMAC physical 
function subscale, Pearson’s r was also calculated. 
 
Finally, known-groups validity was investigated by comparing scores on each of the 
performance-based measures for individuals who walked with a gait aid versus those who 
walked without a gait aid.  A statically significant difference using an independent t-test 
identifies that known-groups validity is achieved. 
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Chapter 4 
Results 
Eighty-five patients we approached as potential participants.  Those who did not enter the 
study had undergone revision surgery (1) or were unwilling to participate (1).  Eighty-
three participants were entered into the study (Figure 2.).  Complete data were collected 
on 80 patients. 
During the study two patients did not attend their twelve-week testing sessions.  Multiple 
attempts were made to contact the patients to schedule an appointment however we were 
unsuccessful.  One subject was excluded in the sensitivity to change portion of the study 
as she had a respiratory infection and could not complete the 30CST.  The final sample 
consisted of eighty-one patients who attended testing session at all three time points 
(initial visit, six weeks and twelve weeks postoperative).  Forty-five patients completed a 
second testing session 24-48 hours following the six-week testing and thirty-seven 
patients completed a second testing session 24 to 48 hours following the twelve-week 
testing session to evaluate test-retest reliability of the two PBOMs. 
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Figure 2 - Enrollment Flow Chart 
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Figure 2. Enrollment flow chart  
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A summary of patient characteristics is outlined below (Table 1) including; age, height, 
weight, BMI, length of postoperative stay in hospital, number of comorbidities, number 
of home care visits, days from surgery to initial testing and use of gait aid at during initial 
testing session. 
 
Table 1. Patient Characteristics  
 
 
 
 
 
 
 
 
 
 
 
 
Mean ± Standard Deviation 
 Female Subjects Male Subjects Total 
Sample size (n) 52 31 83 
Age (y) 67.6 ± 8.8 69.5 ± 8.5 68.3 ±8.7 
Height (m) 1.62 ± 0.07 1.75 ± 0.08 1.67 ± 0.10 
Weight (kg) 89.8 ± 19.9 96.4 ± 16.0 92.3 ± 18.7 
Body mass index 34.01 ± 6.45 31.38 ± 4.20 33.02 ± 5.83 
Length of stay (days) 2.48 ± 1.04 2.10 ± 0.91 2.34 ± 1.00 
Co-morbidities (n) 2.50 ± 1.50 1.68 ± 1.14 2.19 ± 1.43 
Home care visits (n) 3.63 ± 1.1 3.65 ± 0.8 3.64 ± 1.0 
Days from surgery (days) 29.87 ± 5.77 28.45 ± 5.12 29.24 ± 5.55 
Gait aid at initial testing (n) 38 21 59 
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A summary of statistics for the 30CST scores, 10MWT scores, knee flexion range of 
motion in degrees, WOMAC physical function (WOMACpf) scores and Global Rating of 
Change function (GRCf) on all test occasion are below in Table 2.   
 
Table 2. Mean ± Standard Deviation for All Subjects for 30CST, 10MWT, Knee Flexion, 
WOMACpf and GRCf on Five Separate Test Occasions 
 
For all tests completed, paired t-tests determined that all the scores on each test occasion 
were significantly different.   
For the 30CST there was a significant difference in all scores between all test occasions 
(p < 0.001), this included a significant difference between test occasions 2 and 3, and 4 
and 5, which were collected to establish test-retest reliability.   
The results of the 10MWT were similar in that scores between all test occasions were 
significantly different.  The difference between the scores obtained on the first and 
second test occasion was significant with p < 0.01.  Between score differences on test 
occasion 1 and 3 were p < 0.005.  For the remainder of the scores, the comparison 
between test occasions 2-3, 3-4 and 4-5 were significantly different (p < 0.001). 
Test Initial Testing 6-wk Postop 6-wk re-test 12-wk Postop 12-wk re-test 
N 83 83 45 81 37 
30CST (n) 4.2 ± 3.9 8.7 ± 3.9 9.2 ± 3.5 12.2 ± 3.76 12.8 ± 2.9 
10MWT (s) 14.88 ± 9.32 10.45 ± 2.95 9.97 ± 2.2 8.30 ± 1.96 8.12 ± 1.61 
Knee 
Flexion (°) 
100.6 ± 15.2 112.6 ± 11.5 - 120.8 ± 8.32 - 
WOMACpf 33.4 ± 13.6 24.66 ± 12.4 - 16.28 ±12.1 - 
GRCf - 4.4 ± 2.1 - 5.77 ± 1.1 - 
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Objective 1 – Test-retest Reliability 
Reliability statistics for the 30CST and 10MWT are outline in Tables 3 and 4.  These 
values were calculated at both 6 weeks and 12 weeks post op.   
 
Table 3. Reliability for All Subjects (n=45) Between Test Occasions Two and Three (6 
Weeks Postoperatively): Mean Difference, Interclass Correlation Coefficients (ICC), 
Standard Error of Measurement (SEM) Minimal Detectable Change Estimated Using the 
z Value for 90% Confidence (1.64) 
 
Test Mean Difference (95%CI) ICC (95%CI) SEM (95%CI) MDC90 
30CST -0.91 (-1.20 to -0.62) 0.96 (0.93 to 0.98) ±0.67 (0.57 to 0.87) ±1.56 
10MWT 1.04 (0.50 to 1.49) 0.82 (0.70 to 0.90) ±1.05 (0.88 to 1.34) ±2.43 
 
 
Table 4. Reliability for All Subjects (n=37) Between Test Occasions Four and Five (12 
Weeks Postoperatively): Mean Difference, Intraclass Correlation Coefficients (ICC), 
Standard Error of Measurement (SEM) Minimal Detectable Change Estimated Using the 
z Value for 90% Confidence (1.64) 
 
Test Mean Difference (95%CI) ICC (95%CI) SEM (95%CI)  MDC90 
30CST -0.97 (-1.35 to -0.59) 0.93 (0.86 to 0.96) ±0.79 (0.66 to 1.05) ±1.84 
10MWT 0.53 (0.26 to 0.80) 0.89 (0.80 to 0.94) ±0.57 (0.47 to 0.75) ±1.32 
 
For the 30CST at 6 weeks postoperatively the ICC (0.96, 95%CI 0.93 to 0.98) and SEM 
(±0.67, 95%CI 0.57 to 0.87) indicated acceptable reliability. The same is true for 12 
weeks postoperatively where the ICC (0.93, 95%CI 0.86 to 0.96) and SEM (±0.79, 
95%CI 0.66 to 1.05) also confirmed adequate reliability.  The minimal detectable change, 
at the 90% confidence interval, was 1.56 stands and 1.84 stands at 6 and 12 weeks 
following surgery respectively. 
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For the 10MWT at 6 weeks postoperatively the ICC (0.82, 95%CI 0.70 to 0.90) and SEM 
(±1.05, 95%CI 0.88 to 1.34) were also satisfactory.  The same can be said at 12 weeks 
postoperatively with the ICC (0.89, 95%CI 0.80 to 0.94) and SEM (±0.57, 95%CI 0.47 to 
0.75).  The minimal detectable change, at the 90% confidence interval, was 2.43 seconds 
and 1.32 seconds at 6 and 12 weeks following surgery respectively. 
 
Figure 3 – Bland-Altman plot for test-retest agreement of the 10MWT at 6 weeks 
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Figure 4 – Bland-Altman plot for test-retest agreement of the 30SCST at 6 weeks 
 
 
 
Figure 5 – Bland-Altman plot for test-retest agreement of the 10MWT at 12 weeks 
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Figure 6 – Bland-Altman plot for test-retest agreement of the 30CST at 12 weeks 
 
 
Objective 2 – Longitudinal Validity 
When comparing the 30CST and 10MWT scores from initial to 6 weeks following 
surgery to 12 weeks following surgery, there was an improvement in each performance-
based measure as the time from surgery increased.  The same was observed with the 
WOMACpf scores. 
Change scores, SRMs and ES for the 30CST, 10MWT and WOMACpf from initial visit 
to 6 weeks postoperative and initial visit to12 weeks postoperative are summarized in 
Table 5-7.  For each time interval, the 30CST had the greatest SRM followed by the 
WOMACpf than the 10MWT. For the 30CST, from initial to 6 weeks postoperative, the 
SRM (1.94) and ES (1.16) indicated that the performance-based outcome measures are 
sensitive to clinical change.  The results were similar from initial to 12 weeks 
postoperative with an SRM 1.94 and ES 2.07. 
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Table 5. Initial to 6 Weeks Postoperative: Mean change scores (scores from trial 2 - trial 
1) for 30CST and 10MWT and WOMACpf 
.  
Test Mean change score (95% CI) SRM  ES 
        
30CST 4.55 (3.70 to 5.30) 1.30 1.16 
10MWT 4.42 (2.71 to 6.13) 0.56 0.48 
WOMACpf 8.69 (6.29 to 11.08) 0.79 0.64 
 
Table 6. 6 to 12 Weeks Postoperative: Mean change scores (scores from trial 4 - trial 2) 
for 30CST and 10MWT and WOMACpf 
 
Test Mean change score (95% CI) SRM  ES 
        
30CST 3.54 (2.85 to 4.22) 1.14 0.90 
10MWT 2.17 (1.71 to 2.62) 1.06 0.74 
WOMAC 8.06 (5.88 to 10.25) 0.82 0.65 
 
Table 7. Initial to 12 Weeks Postoperative: Mean change scores (scores from trial 4 - 
trial 1) for 30CST and 10MWT and WOMACpf 
 
Test Mean change score (95% CI) SRM  ES 
        
30CST 8.12 (7.20 to 9.05) 1.94 2.07 
10MWT 6.65 (4.74 to 8.58) 0.77 0.71 
WOMACpf 16.67 (14.14 to 19.19) 1.46 1.23 
 
Pearson correlation coefficients (r) were calculated to explore the association between the 
change scores on the two performance-based outcome measures, change score of the 
WOMACpf and the GRCf.  Values were calculated for changes between initial testing 
and 6 weeks postoperative and initial testing and 12 weeks postoperative.  Correlations 
between the two performance-based tests and self-report measures ranged from -0.16 to 
0.34.  The strongest association was between the 30CST and GRCf at both time frames.  
Results are summarized in Tables 8-9 below. 
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Table 8. Pearson r Values (95%CI) for Correlations Between the 30CST Change Scores, 
10MWT Change Score, WOMACpf Change Score and GRC Function and Pain from 
Initial Testing to 6 Weeks Postoperative 
 
Test  
Global Rating of 
Change Function 
Global Rating of 
Change Pain 
WOMACpf Change 
Score 
        
30CST 0.34 (0.13 to 0.52) 0.28 (0.07 to 0.47) 0.22 (0 to 0.42) 
10MWT 0.05 (-0.17 to 0.26) 0.03 (-0.19 to 0.24) 0.22 (0 to 0.42) 
WOMACpf -0.10 (-0.31 to 0.12) 0.07 (-0.15 to 0.28) - 
 
Table 9. Pearson r Values (95%CI) for Correlations Between the 30CST Change Scores, 
10MWT Change Score, WOMACpf Change Score and GRC Function and Pain from 
Initial Testing to 12 Weeks Postoperative 
 
Test  
Global Rating of 
Change Function 
Global Rating of 
Change Pain 
WOMACpf Change 
Score 
        
30CST 0.25 (0.03 to 0.45) 0.23 (0.01 to 0.43) 0.15 (-0.07 to 0.36) 
10MWT -0.16(-0.37 to 0.06) -0.01(-0.23 to 0.21) 0.11 (-0.11 to 0.32) 
WOMACpf 0.07 (-0.15 to 0.28) 0.22 (0.002 to 0.42) - 
 
The GRCf responses were then grouped into 0 (0-1 no change), 1 (2-3 little change), 2 (4-
5 moderate change) and 3 (6-7 large change) and presented using a stem and leaf plot 
(Figures 3-6).  On observation, we see that those who felt they had a greater improvement 
in function also had a greater change in their performance on a functional test  
demonstrating responsiveness.  Association between the 10MWT and self-report 
measures was not as strong. 
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Figure 7 - Comparison of Grouped GRC and 30CST change score at 6 weeks 
 
 
Figure 8 - Comparison of Grouped GRC and 10MWT change score at 6 weeks 
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Figure 9 - Comparison of Grouped GRC and 30CST change score at 12 weeks 
 
 
Figure 10 - Comparison of Grouped GRC and 10MWT change score at 12 weeks 
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Objective 3 – Concurrent Validity 
Correlations were then examined between the 30CST, 10MWT and WOMACpf at each 
of the three testing time points and summarized in Tables 10-12 below.  Similar to the 
association in change score, the correlations at one time point between the two 
performance-based measures and the WOMACpf score ranged between -0.05 and -0.33 
for the 30CST and 0.21 to 0.27 for the 10MWT.  Association was greater between the 
30CST and WOMACpf scores at initial testing and 12 weeks post op than the 10MWT 
and WOMACpf score.  The 10MWT had a greater association with the WOMACpf score 
at six weeks postoperative.  The association between the two performance-based outcome 
measures increased the further out from surgery and ranged from -0.34 to -0.57. 
 
Table 10. Pearson r Values (95%CI) for Correlations between 30CST, 10MWT and 
WOMACpf at Initial Test Occasion 
 
Test  WOMACpf 30CST 10MWT 
        
30CST -0.33 (-0.51 to -0.12) - -0.34 (-0.52 to -0.13) 
10MWT 0.22 (0.01 to 0.42) -0.34 (-0.52 to -0.13) - 
WOMACpf - -0.33 (-0.51 to -0.12) 0.22 (0 to 0.42) 
 
Table 11. Pearson r Values (95%CI) for Correlations between 30CST, 10MWT and 
WOMACpf at 6 Weeks Postoperative Test Occasion 
 
Test WOMACpf 30CST 10MWT 
        
30CST -0.05 (-0.26 to 0.17) - -0.47 (-0.62 to -0.28) 
10MWT 0.27 (0.06 to 0.46) -0.47 (-0.62 to -0.28) - 
WOMACpf - -0.05 (-0.26 to 0.17) 0.27 (0.06 to 0.46) 
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Table 12. Pearson r Values (95%CI) for Correlations between 30CST, 10MWT and 
WOMACpf at 12 Weeks Postoperative Test Occasion 
 
Test  WOMACpf 30CST 10MWT 
        
30CST -0.16 (-0.37 to 0.06) - -0.57 (-0.70 to -0.40) 
10MWT 0.21 (-0.01 to 0.41) -0.57 (-0.70 to -0.40) - 
WOMACpf - -0.16 (-0.37 to 0.06) 0.21 (-0.01 to 0.41) 
 
Known-groups validity was examined to help establish if the two performance-based 
outcome measures could differentiate between those who were using a gait aid or not 
while completing the functional test.  At all three testing occasions the mean scores 
between those with a gait aid and those without were all significantly different indicating 
the functional tests could differentiate between the two groups (Table 13). 
Table 13. Mean ± Standard Deviation of Performance-Based Outcome Measure Score by 
Use of Gait Aid 
 
 Gait Aid (n) No Gait Aid (n) 
10MWT Score (s)   
Initial  16.81 ± 10.40 (59) 10.12 ± 1.90 (24) 
6 Week Post Op 12.50 ± 3.03 (32) 9.17 ± 2.05 (51) 
12 Week Post Op 10.60 ± 1.71 (15) 7.75 ± 1.61 (66) 
30CST Score (n)   
Initial  3.39 ± 3.41 (59) 6.04 ± 4.51 (24) 
6 Week Post Op 7.00 ± 3.93 (32) 9.78 ± 3.60 (51) 
12 Week Post Op 10.00 ± 4.00 (15) 12.69 ± 3.55 (66) 
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Chapter 5 
Discussion 
This study evaluated the measurement properties of the 30CST and 10MWT in patients 
during the first 12 weeks of postoperative rehabilitation following TKA.  Through this 
study we were able to determine that these performance-based outcome measures can be 
used as standardized outcome measures in those following TKA.  The test-retest 
reliability of the two measures is adequate as the presented ICC values are well above the 
accepted value of 0.7074.  Estimates of measurement error and minimal detectable change 
in these scores are also provided for both the 6 and 12 week intervals following surgery 
which can assist clinicians in determining if a true change has occurred with respect to 
their patient’s functional status.  Not only can these measurements be considered reliable, 
but they are also sensitive to change as indicated by the change in scores over time and 
calculated standardized response mean and effect size. Correlations between the change 
scores on the two performance-based outcome measures and self-report measures, 
including the WOMACpf and GRCf show that those who felt they had a greater 
improvement in function also had a greater change in their performance on a functional 
test.  When evaluating the correlation between the WOMACpf and the two performance-
based measures at a single time point the association is low to moderate at best, 
concluding that both self-report measures and performance- based measures are required 
to capture the overall function of those following TKA. 
The ICC’s reported in this study suggest not only adequate, but excellent relative 
reliability and signify that the 30CST and 10MWT are suitable for differentiating 
between patients during rehabilitation following TKA.  For test-retest reliability the 
current study’s findings are similar to those ICC values published in previous research.  
ICCs for the 30CST ranged from 0.93 to 0.96 depending on the time of evaluation during 
rehabilitation, either 6 weeks or 12 weeks postoperatively.  Gill et al.,63 reported ICCs 
from 0.95 to 0.98 for those with knee osteoarthritis awaiting TKA.  The ICC’s reported in 
the present study were higher than those reported by Dobson et al.,86 and Tolk et al.,74 
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(0.85 to 0.90).  Again, populations observed in these studies were those with 
osteoarthritis who may or may not be awaiting arthroplasty surgery.   
Relative reliability for the 10MWT was estimated from 0.82 to 0.89; this was established 
by using the mean of the two trials during each testing session.  Estimated values were 
slightly lower than those reported in the literature.  Previous research has examined a 
variety of gait speed tests using different distances and protocols.  Using the 50FWT and 
a protocol that the current study was modeled after, Gill et al.,63 estimated ICCs ranging 
from 0.93 to 0.97.  The protocol used by Fransen et a.,l65 required each participant to 
walk a course of 8 metres.  ICCs were consistently high ranging from 0.90 to 0.98.     
Each of these studies allowed for four to five trials of the walk test and noted a significant 
difference in the first and second test trials which stabilized for the remainder of the trials 
indicating a learning curve was probable and a practice trial should be allowed.  In our 
study a significant difference was found between all test occasions, including those used 
to establish test-retest reliability.  Perhaps allowing for a practice trial and using values 
once scores had stabilized would have changed this.  As well, our population was in the 
initial stages of rehabilitation following TKA, not those with osteoarthritis awaiting a 
TKA; this could also contribute to the difference in scores.  We would assume that 
patients would remain stable between testing sessions, but other confounding factors, 
such as pain management and other activities completed that day may influence their test 
score.   
Similarly, published values for the SEM and MDC90, measuring absolute reliability have 
been estimated using individuals with knee osteoarthritis.  To our knowledge no studies 
have explored these measurement properties in those during rehabilitation following 
TKA.  These values are reported in a measure’s scale points and allow a clinician to 
estimate the reliability of the measurements they take.  As patients following TKA may 
improve differently depending on the stage of recovery they are in, it is important that 
absolute reliability values be estimated at these different time points to accurately 
interpret the results.   
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Previous research has estimated the SEM for the 30CST to be from 0.70 to 1.27 
stands61,63,73,74   and the MDC90 to be from 1.64 to 2.4 stands.61,63,73,74  At 6 weeks 
postoperative our study reported the SEM for the 30CST to be 0.67 and at 12 weeks 
postoperative the SEM was calculated to be 0.79.  Based on the estimated error in the 
30CST at 6 weeks postoperative (SEM x 1.96 = ±1.31), a clinician can be 95% confident 
that a measured value of 8 stands could vary from 6.7 to 9.3 stands, simply due to 
measurement error.  At the 12 week postoperative mark (SEM x 1.96 = ±1.55) this same 
score could vary from 6.5 to 9.6 stands.  With the calculated MDC90, 90% of stable 
patients would change less than 1.56 stands at 6 weeks and 1.84 stands at 12 weeks 
following surgery. 
Comparing this study’s findings for the 10MWT to the literature is somewhat more 
difficult as measures of gait speed are often varied with respect to distance walked, 
selected pace and reported scale values (seconds versus m/s).  If we compare our results 
to the protocol our study was modeled after, Gill et al.,63 report the SEM and MDC90 for 
the 50FWT to be 1.32 seconds and 3.08 seconds respectively.  The subjects in this study 
were awaiting a total hip or knee replacement and participating in a six-week exercise 
program prior to surgery.  Values were estimated from baseline scores and not following 
the intervention.  We estimated the SEM to be 1.05 seconds at 6-weeks post op and 0.57 
at 12 weeks postoperative.  Based on an estimated error in the 10MWT at 6 weeks 
postoperative (SEM x 1.96 =  ±2.06), a clinician can be 95% confident that a measured 
value of 10.56 seconds could vary from 8.50 to 12.62 seconds, due solely to measurement 
error.  At the 12 week mark (SEM x 1.96 = ±1.12) this same score could vary from 9.44 
to 11.68 seconds.  Furthermore, with a calculated of MDC90 of 2.43 seconds at 6 weeks 
and 1.32 seconds at 12 weeks, 90% of stable patients would change by less than 2.43 or 
1.32 seconds.  
When comparing the results of the two tests we observed that the MDC90 for the 
10MWT decreased over time whereas the opposite occurred for the 30CST.  This may be 
due to the greater variability in scores during the 10MWT observed during the earlier 
stages of recovery due to use of a gait aid, effect of surgery on ambulation and other 
contributing impairments to gait. 
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Using established performance-based measures, which have adequate reliability is 
essential; however, in clinical practice using a measure that is able to detect change in an 
individual makes the measure’s use clinically relevant.  Change scores, standardized 
response means, and effect size were calculated to explore the sensitivity to change of the 
30CST and 10MWT.   
For the 10MWT effect size ranged between 0.48 to 0.74, which as described by Cohen 
indicates a moderate to large effect.56 Standardized response mean values were calculated 
from 0.56 to 1.06, which again can be considered moderate to high.  The highest values 
were obtained between measurements taken at the 6 week and 12 week mark indicating 
that at different times the ability of the 10MWT to detect change is better. These findings 
are similar to Borjesson et al.,78 who evaluated 54 individuals following 
unicompartmental knee arthroplasty prior to surgery and at one year post-operatively.  ES 
ranged from 0.34 to 0.58 and SRM from 0.49 to 0.71.  The ability to detect change was 
best when a slow gait speed was used; this may help direct selection of a test when 
considering fast-paced versus self-paced walk test. 
A similar trend was found with the 30CST where ES and SRM ranged from 0.90 to 2.07 
and 1.14 to 1.94 respectively.  In the case of the 30CST the highest values obtained were 
between measurements taken at initial testing and 12 weeks postoperative.  Values for 
both measures were lower in the period evaluating change between initial testing and 6 
weeks postoperative, this may have been due to the little time that was allotted for change 
to occur.  The mean time in days between initial testing and 6-week testing was 14.77 
days (SD ±6.1) with the number of days ranging from 5 to 35 days.  The interquartile 
range during this period was 7 days.  The ability to detect change in a shorter period of 
time would be more challenging than given a sufficient amount of time when we would 
expect a change to occur. 
Overall the 30CST was able to detect change better than the 10MWT between all time 
points.  Gill et al.,64 reported a similar trend with the 30CST demonstrating a large 
responsiveness (0.84) compared to the moderate result (0.45) from the 50FPWT.  This 
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finding may help clinical decision-making when selecting an outcome measure to be used 
in clinical practice.  Not only is the 30CST easier to administer than the 10MWT, but its 
superior ability to detect change may make it the test of choice if their time for collecting 
measures is a factor. 
Our validity results agree with previous reports that performance-based measures and 
self-report measures are, at best, moderately correlated57  When exploring change scores 
between the initial and 6-week testing, correlations between the change in the 30CST and 
GRCf (r = 0.34) and WOMACpf (r = 0.22) indicated that the change in ability to sit to 
stand is only fairly57 associated with perceived change in function. The correlation was 
similar when change scores between initial and 12-week testing were examined; GRCf (r 
= 0.25) and WOMACpf (r = 0.15).   
Correlation between the 10MWT change score and GRCf (r = 0.05) and WOMACpf 
change score (r = 0.22) at 6- weeks and GRCf (r = -0.16) and WOMACpf change score 
(r = 0.11) were significantly less than the 30CST.  The GRC is commonly used in 
musculoskeletal research to identify and quantify a patient’s change over time; however 
the GRC places a significant cognitive demand on the patient84, in our case to remember 
what they were like when they first began physiotherapy at University Hospital. The 
GRC scale used in this study was a 15 adjectival scale ranging from -7 (a very great deal 
worse) to +7 (a very great deal better).  To evaluate responsiveness, we grouped the 
responses where those answering 0-1 indicated no change, 2-3 was a small amount of 
change, 4-5 and moderate amount of change and 6-7 a large amount of change.  The 
results were then analyzed using a stem and leaf plot.  From this we can visualize that 
those who felt that they had a greater change in function also had a greater change score 
on both the 30CST and 10MWT.  The exception was with the 10MWT at 12 weeks 
which could be associated with a potential ceiling effect. 
Correlation at a single time point between the WOMACpf and 30CST ranged from –0.05 
to -0.33.  For the 10MWT values were fairly consistent over the three test occasions (r = 
0.21 to 0.27).  These findings are similar to Tolk et al.,74 yet compared to other studies 
where the performance-based measures were correlated to self-report measures of 
outcome64,69,77 the correlation is lower.  One reason for this may be the difference in the 
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population that our study was exploring the measurement properties in.  Previous 
literature tended to focus on those with osteoarthritis awaiting TKA where individuals 
may have been more stable and homogeneous.  Their perceived function and influence of 
pain on perceived function would be very different than an individual who had just 
undergone joint replacement surgery.  Those studies that did include postoperative 
patients evaluated them at time points outside of the first three months in rehabilitation.78 
Establishing measurement properties in performance-based outcome measures is 
important but it is only the first step.  Encouraging utilization and assisting in interpreting 
results to drive clinical decision-making is key to ensure translation of research into 
practice.  The potential clinical use is demonstrated in the following example: 
Your patient is a 71-year-old male who underwent a right total knee arthroplasty 3 
months ago.  Six weeks ago, you evaluated his lower extremity strength and gait speed 
using the 30CST and 10MWT.  He was able to complete 9 stands in 30 seconds and the 
mean score of his two trials on the 10MWT was 11.62 seconds.  Following this you 
implemented a progressive strengthening and walking program as he is planning on 
returning to golf as soon as he is able to.  Both you and the patient would like to evaluate 
whether his strength and gait speed have changed over the six weeks of training.  You 
repeat the tests and today he is able to complete 15 stands and walk the 10-metre course 
in 7.01 seconds. 
• What is the patient’s level of functional performance today? 
The patient’ s 30CST is 15 stands, and you can be 95% confident that the true number of 
stands lies between 13.5 and 16.5 stands.  The patient’s 10MWT was completed in 7.01 
seconds.  You can be 95% confident that the true time is between 5.89 and 8.13 seconds 
(see Table 4). 
• Has the patient’s functional performance truly improved over the past 6 weeks 
of training? 
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You know that 90% of stable patients would be expected to change by less than 1.84 
stands and 1.32 seconds.  As his 30CST improved by 6 stands and his 10MWT improved 
by 4.61 seconds, you can be confident he has truly improved (see Table 4). 
• How would your assessment change if you wanted to use a performance-based 
measure, but you have a busy day in clinic and cannot afford the time required 
to administer both tests? 
 
Overall the 30CST had the highest relative reliability and high sensitivity to change 
(SRM = 1.14, ES = 0.90) between 6 and 12 weeks following surgery.  The SRM and 
MDC90 were only slightly higher for the 30CST than the 10MWT at the three-month 
time point.  Correlation to the GRCf and WOMACpf were low for both the 30CST and 
10MWT, to note the correlation between the two performance-based measures at 3 
months was considered moderate (-0.57).  If a clinician had to pick one test to complete, 
the 30CST may be the best option.  This test also requires less time to complete and set 
up is more amenable to limited space. 
 
The objectives of this study were to examine the test retest reliability, longitudinal 
validity and concurrent validity of the 30CST and 10MWT in patients following TKA.  
This was accomplished, as the relative reliability and absolute reliability were determined 
at two time points along with the SRM and ES.  Further support for using these 
performance-based measures was provided by revealing low to moderate correlations to 
the GRCf and WOMACpf.  The results suggest that using these two performance-based 
measures is appropriate for those undergoing rehabilitation following total knee 
arthroplasty. 
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Limitations 
The limitations of the study are as follows:   
1) Patients were completing rehabilitation at the same centre; however, specific 
interventions would be based on the patient’s individual situation and therapist 
treatment philosophies.  The variation in treatment may impact the level and pace 
of improvement.  For example, if patient A had been introduced to the sit test in 
week 1 of treatment as an exercise vs. patient B who had not been introduced to 
sit to as an exercise until week 6, the level of improvement would vary possibly 
due to familiarity of the exercise. 
2) There was some variation in the time when participants entered the study (i.e. 
their first postoperative physical therapy assessment). The mean (SD) time from 
surgery to first physical therapy visit was 29.24 (±5.55) days.  The 6-week and 
12-week assessments were based on the time from surgery. 
Strengths 
1) The study met the required sample size to explore both our validity and reliability 
objectives.  Only two subjects were lost to follow up. 
2) The demographics of the sample suggest the results are generalizable to those 
who have undergone a unilateral TKA and are appropriate for those who are 
undergoing rehabilitation following TKA. 
3) The study evaluated the measurement properties and established point estimates 
and described the MDC90 for the two PBOM at both 6 weeks and 12 weeks 
following TKA.  This will allow clinicians to be confident in their interpretation 
of results during testing sessions at different time points in recovery. 
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Summary and Recommendations 
1) Both performance-based outcome measures are feasible and easy to administer.  
Compared to other recommended tests (40MFWT, Stair Climb Test), these 
require little equipment and time to administer.  These measures capture aspects 
of function that are important for individuals following TKA and assist both 
clinician and patient in realizing change has occurred and not just relying on self-
report and impairment measures which may not fully capture functional change. 
 
2) This study explored the measurement properties of the tests in the first 12 weeks 
following TKA.  There is a need to continue to measure these tests further out in 
the recovery process.  This may also assist in implementation of rehabilitation 
guidelines where discharge from physiotherapy was based more on function than 
time. 
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Appendix A - Letter of Information and Consent 
 
Reliability and Validity of Two Performance Based Outcome Measures in 
Rehabilitation Following Total Knee Arthroplasty 
 
You are being invited to voluntary participate in this research study as you have recently 
had a total knee replacement at London Health Science Centre – University Hospital.   
 
This letter of information describes the research study and your role as a participant.  
The purpose of this letter is to provide you with information required for you to make an 
informed decision regarding participation in this research.  Please read this form 
carefully.  Do not hesitate to ask anything about the information provided.  The study 
supervisor, Dr. Trevor Birmingham, or co-investigator, Jen Van Bussel describe the 
study and answer any questions you may have.  This project is part of the requirements of 
a Master of Science degree for Jen Van Bussel, who will be collecting the data. 
 
Study Purpose 
 
The purpose of this study is to determine the reliability (precision) and validity 
(accuracy) of the 30 Second Chair Stand Test (30 CST) and 10 Metre Walk Test (10 
MWT) during rehabilitation in patients following total knee arthroplasty (TKA).  Using 
reliable and valid outcome measures during rehabilitation will help evaluate 
improvements in physical function and assist in making decision regarding treatment. 
 
Procedure 
 
If you choose to participate in the study, you will be asked to fill out the Western Ontario 
and McMaster Universities Osteoarthritis Index (WOMAC) and complete the 30 CST 
and 10 MWT as part of your standard physiotherapy assessment today.  These measures, 
along with the Global Rating of Change (GRC) will be repeated as part of a standard 
assessment during your scheduled follow-up visits with your physiotherapist at 6 weeks 
and 12 weeks following surgery.  Study participation involves you attending two extra 
sessions where you will be asked to repeat the 30 CST and 10 MWT.  These sessions will 
occur 24-48 hours after your 6-week and 12-week physiotherapy follow-up visit.  These 
sessions will take approximately 10 minutes of your time to complete.   
 
Risks 
 
The perceived risks of participation are minimal.  As with any test of physical function 
that requires you to be standing or walking there is a risk of falling.  Allowing you to use 
any gait aid you require during the 10 MWT will control this risk. Furthermore, during 
the 30 CST and 10 MWT the tester will remain in close proximity to you to provide 
assistance if required.   
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Completion of the 30 CST and 10 MWT may cause a temporary increase in symptoms, 
which is similar to the risk associated with any physiotherapy session.  You are in 
complete control of all aspects of these tests, and may stop at any point if you choose. 
 
Personal data will be gathered for this study.  There is a risk for breaching confidentiality 
of this information; however procedures are set in place to minimize this risk (see below). 
 
Benefits and Compensation 
 
There are no direct benefits to you as a result of participation in this study.  Participation 
in this study may help physiotherapists in the future select reliable and valid outcome 
measures to use during rehabilitation following TKA.  In turn this will help future 
patients, physiotherapists and surgeons measure true functional change and assist in 
clinical decision making.  
 
Reimbursement 
 
You will be reimbursed for parking expenses accrued during the five session, as outlined 
above, when testing will occur. 
 
Voluntary Participation 
 
Your participation in this study is voluntary.  You may refuse to participate or 
discontinue your participation at any time without affecting the medical care being 
provided to you in any way.  Should you choose to withdraw, information collected will 
only be done as part of your standard assessment and not used in this study.  The de-
identified data you have contributed to that point may be used to help answer our 
research question. 
 
Confidentiality 
 
Your confidentiality will be respected.  You will be given an identification number, by 
your physiotherapist, to use with your data collection forms.  All information collected 
for this study will be kept confidential and identified by this number.  All information 
collected will be stored in a locked cabinet and entered onto a secure password protected 
server at University Hospital.  A list linking your identification number with your name 
will be kept on a secure password protected server at University Hospital, separate from 
your study file.  All information will be kept in a secure and confidential location for a 
minimum of 15 years. 
 
The results of this study may be used in presentations or published in a peer reviewed 
scientific journal.  Only group averages will be reported and your name and identity will 
not be disclosed. 
 
Qualified representatives of the Lawson Quality Assurance Education Program may look 
at your medical/clinical study records at the site where those records are held, for quality 
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assurance (to check that the information collected for the study is correct and follows 
proper laws and guidelines). 
 
You will be given a copy of this letter of information and consent form once it has been 
signed.  You do not waive any legal rights by signing the consent form.  Representatives 
of the University of Western Ontario Health Sciences Research Ethics Board my contact 
you or require access to your study-related records to monitor the conduct of the research. 
 
If you have any questions about your rights as a research participant or the conduct of this 
study, you may contact the Patient Experience Office at LHSC. or access the online form 
at: https://apps.lhsc.on.ca/?q=forms/patient-experiencecontact-form. 
 
We thank you in advance for considering participation in this study. 
 
Sincerely, 
 
Dr. Trevor Birmingham PT, PhD 
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Consent Form 
 
Reliability and Validity of Two Performance Based Outcome Measures in 
Rehabilitation Following Total Knee Arthroplasty 
 
 
I have read the letter of information, have had the nature of the study explained to me and 
I agree to participate. All questions have been answered to my satisfaction.  
 
 
 
 
 
 
Participant name (print) 
 
 
 
 
 
Participant signature       Date   
     
 
 
 
 
Person obtaining consent (print) 
 
 
 
 
 
Signature of person obtaining consent    Date    
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Appendix B – Data Collection Form 
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Appendix C – Performance Based Outcome Measures 
 
Performance – Based Outcome Measures of Function 
 
30 Second Chair Stand Test (30 CST) 
 
The 30 CST assesses functional lower extremity strength and dynamic balance through 
an evaluation of the ability to rise from a chair and sit back down repeatedly over 30 
seconds (Bennell, 2011).  The test is easy to administer and requires the use of a 
stopwatch and straight back chair with a 17-inch seat height without arms.  The test has 
demonstrated both reliability and validity in those awaiting joint replacement surgery of 
the hip or knee (Gill 2008; 2012). 
 
10 Metre Walk Test (10 MWT) 
 
A self-paced walk test is used in many groups, including those with hip and knee OA.  
Gait speed has been established as a responsive and predictive measure for multiple 
patient populations (Bennell, 2011).  The test requires the participant to walk as fast as 
they can, safely, over a distance of 10 metres.  Gait aids may be used as required during 
the test and use will be noted by the tester. 
 
Protocol for the 30 Second Chair Stand Test 
 
Patient Set Up 
 
1. Use a chair with a 17-inch seat height. 
2. Place the chair against a wall to prevent it from moving. 
3. Sit the patient comfortably in the middle of the chair. 
4. Allow the patient to position their feet where they are comfortable. 
5. Ask them to cross their arms across their chest. 
 
Instructions to Patient 
 
1. “This test looks at how many times you can stand and sit from a chair in 30 
seconds.” 
2. “If you do not fully stand or sit down so that your bottom touches the seat, that 
repetition will not be counted.” 
3. Demonstrate movement. 
4. Allow one practice stand by the patient. 
5. “When I say “GO”, I want you to stand up and sit down as many times as you can 
in 30 seconds.” 
6. “If you have pain that becomes too uncomfortable, you are allowed to stop the 
test.” 
7. “Do you understand what you need to do?” 
8. “Are you ready?” 
9. “Ready, set GO.” 
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General Guidelines 
 
1. If the patient is more than halfway up at the end of 30 seconds, it counts as a full 
stand. 
2. Do not offer any encouragement before or after each test other than “well done”. 
3. If the patient expresses concern about performing a task, tell them to “do the best 
that you can”. 
 
(Adapted from: Gill and McBurney, 2008, p.151) 
 
Protocol for the 10 Metre Walk Test 
 
Patient Set Up 
  
1. Mark out a 14-metre walkway with lines at 0m, 2m, 12m and 14m. 
2. Instruct the patient to stand with toes touching the line at the 0m mark. 
 
Instructions to Patient 
 
1. “I am going to time how fast you can walk 10 metres” 
2. “I want you to go as fast as you can safely walk. You will walk from the yellow 
line to the other yellow line at the end of the walkway.” 
3. Demonstrate the test and show the patient where the end line is.  
4. “I want you to start when I say “GO”, and I will give you a “Ready, Set, GO”” 
5. “If you have pain that becomes too uncomfortable, you are allowed to stop the 
test” 
6. “Do you understand what you need to do?” 
7. “Are you ready?” 
8. “Ready, set, GO” 
 
General Guidelines 
 
1. Timing: start the stopwatch as the first part of the patient’s trunk or foot crosses 
the 2m-mark.  This allows for acceleration of gait speed to occur prior to time 
starting.  Stop the stopwatch as the first part of their trunk or foot crosses the 
12m-mark.  This will eliminate the effect of deceleration on test results. 
2. Walk a pace behind the patient to avoid influencing pace but be close enough to 
ensure safety. 
3. The patient can use their usual and most appropriate gait aid. 
4. Do not offer any encouragement before or after the test other than “well done”. 
5. If a patient expresses concern about performing the task, tell them to “do their 
best”. 
 
(Adapted from: Gill and McBurney, 2008, p.151) 
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Appendix D – WOMAC 
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Appendix E – Global Rating of Change Scale  - Pain 
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Appendix F – Global Rating of Change Scale  - Function 
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Appendix G – Ethics Approval 
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